Best Biotech Stocks

Biotech stocks in the covered universe — US-listed biotechnology and biopharmaceutical companies (including clinical-stage names), ranked by market capitalization. Biotech carries elevated clinical/regulatory risk; every figure is delayed data from SEC EDGAR + Finnhub, shown with its as-of date. Informational only — not financial advice.

• Thermo Fisher Scientific (TMO) Health Care — Thermo Fisher Scientific is a leading global provider of mission-critical laboratory equipment, analytical instrumentation, and scientific services for research and clinical markets. ask →
• Regeneron Pharmaceuticals (REGN) Health Care — Regeneron develops and commercializes monoclonal antibody and other biologics therapies across immunology, oncology, infectious disease, and other therapeutic areas. ask →
• Corteva (CTVA) Materials — A leading agricultural company developing and commercializing seeds, crop protection chemicals, and agronomic solutions to improve crop yields and farm productivity globally. ask →
• Cencora (COR) Health Care — North America's largest pharmaceutical and healthcare product distributor, serving pharmacies, hospitals, and health systems with branded and generic drugs, medical supplies, and specialty healthcare services. ask →
• Royalty Pharma (RPRX) Health Care — Royalty Pharma is the leading financier of pharmaceutical innovation, providing capital in exchange for long-term royalty streams on top-tier commercial drug therapies. ask →
• Illumina, Inc. (ILMN) Health Care — Illumina is the global leader in DNA sequencing and array technologies that are foundational to modern genomics research and clinical diagnostics. ask →
• Dover Corporation (DOV) Industrials — A diversified industrial manufacturer providing engineered equipment, components, and digital solutions across vehicle aftermarket, clean energy fueling, imaging/identification, specialized pumps, and climate technologies. ask →
• West Pharmaceutical Services (WST) Health Care — Global leader in injectable drug containment and delivery systems serving biopharmaceutical and medical device manufacturers with primary packaging, drug delivery devices, and contract manufacturing. ask →
• Roivant Sciences (ROIV) Health Care — Roivant Sciences is a biopharma-tech incubator that uses a 'Vant' subsidiary model and computational discovery tools to accelerate the development of transformative therapies for autoimmune and inflammatory diseases. ask →
• International Flavors & Fragrances (IFF) Materials — A global leader in the science and artistry of taste, scent, and bioscience, supplying essential ingredients for the world's most recognized consumer and industrial brands. ask →
• BridgeBio Pharma, Inc. (BBIO) Health Care — BridgeBio translates genetic science into medicines for rare genetic diseases through a decentralized portfolio model, with an FDA-approved lead product in transthyretin amyloidosis and multiple late-stage programs approaching commercialization. ask →
• ARROWHEAD PHARMACEUTICALS, INC. (ARWR) Health Care — A clinical-stage biotechnology company pioneering RNA interference (RNAi) therapeutics to treat a wide array of genetic and chronic diseases by silencing disease-causing genes. ask →
• Axsome Therapeutics, Inc. (AXSM) Health Care — A fully integrated biopharmaceutical company developing innovative CNS treatments, with three FDA-approved commercial products and a deep pipeline of novel candidates. ask →
• Halozyme (HALO) Health Care — Halozyme monetizes its patented hyaluronidase enzyme and microparticle drug delivery technologies through partnerships with major pharma, earning milestone payments and royalties from approved therapies that achieve faster, higher-volume subcutaneous administration. ask →
• Bruker (BRKR) Health Care — Bruker is a global leader in high-performance analytical instrumentation and diagnostic solutions for life sciences and materials research, enabling structural biology, drug discovery, and scientific innovation at molecular levels. ask →
• Alexandria Real Estate Equities (ARE) Real Estate — Alexandria Real Estate Equities is the pioneer and leading owner/developer of specialized laboratory and office space for the life science industry, clustered in high-growth innovation hubs. ask →
• Bio-Rad Laboratories (BIO) Health Care — A multinational life science and clinical diagnostics company providing research tools, diagnostic test systems, and consumables to laboratories and biopharmaceutical manufacturers worldwide. ask →
• IMMUNOVANT INC (IMVT) Health Care — Immunovant is a clinical-stage immunology company developing IMVT-1402, a potentially best-in-class FcRn inhibitor to treat autoimmune diseases driven by pathogenic IgG antibodies. ask →
• Repligen (RGEN) Health Care — Repligen provides critical, high-efficiency bioprocessing technologies and systems that enable biopharmaceutical companies to manufacture life-saving biological drugs. ask →
• Avantor (AVTR) Health Care — Global provider of mission-critical laboratory consumables, specialty chemicals, and biopharmaceutical manufacturing solutions serving life sciences, healthcare, and advanced technology markets worldwide. ask →
• ENPRO INC (NPO) Industrials — Industrial technology company providing proprietary, high-barrier-entry sealing, sensing, and instrumentation solutions for semiconductor, life sciences, and critical infrastructure applications. ask →
• ERASCA INC (ERAS) Health Care — A precision oncology company developing first-in-class RAS/MAPK pathway-targeting therapies for cancers driven by the most frequently mutated oncogene affecting millions of patients annually. ask →
• COGENT BIOSCIENCES INC (COGT) Health Care — Cogent Biosciences is a clinical-stage biotechnology company developing precision protein kinase inhibitors, primarily targeting KIT mutations for the treatment of systemic mastocytosis and other cancers. ask →
• PTC THERAPEUTICS INC (PTCT) Health Care — PTC Therapeutics develops precision medicines and gene therapies targeting rare genetic disorders and serious diseases, generating revenue from approved products and partnered collaboration deals. ask →
• CG ONCOLOGY INC (CGON) Health Care — An early-stage immuno-oncology company developing cretostimogene, a novel therapeutic candidate for high-risk and intermediate-risk non-muscle-invasive bladder cancer (NMIBC). ask →
• LIGAND PHARMACEUTICALS INC (LGND) Health Care — Ligand Pharmaceuticals is a biotechnology firm that generates recurring revenue through royalty interests and the licensing of proprietary drug formulation technologies to pharmaceutical partners. ask →
• TWIST BIOSCIENCE CORP (TWST) Health Care — Twist Bioscience is a synthetic DNA synthesis platform company that enables the design and production of custom DNA molecules for drug development, diagnostics, and research applications. ask →
• TANGO THERAPEUTICS INC (TNGX) Health Care — A precision oncology company utilizing a proprietary functional genomics platform to discover and develop targeted, synthetic-lethal cancer therapies. ask →
• VERADERMICS INC (MANE) Health Care — VeraDermics is a clinical-stage biotech developing an oral, extended-release minoxidil formulation (VDPHL01) to address the 80 million Americans with pattern hair loss who lack effective, convenient, non-hormonal treatment options. ask →
• Caris Life Sciences (CAI) Health Care — Caris Life Sciences delivers precision oncology and molecular profiling solutions that help biopharma companies and physicians make treatment decisions through comprehensive tumor analysis. ask →
• ARCUS BIOSCIENCES INC (RCUS) Health Care — A clinical-stage biotech developing first-in-class and best-in-class small molecules and antibodies for cancer immunotherapy, with lead HIF-2α inhibitor in late-stage trials. ask →
• Organon & Co. (OGN) Health Care — A diversified pharmaceutical company spun from Merck focusing on established branded medicines and medical devices for women's health, infectious disease, and other therapeutic areas. ask →
• CELLDEX THERAPEUTICS INC (CLDX) Health Care — A clinical-stage biopharmaceutical company developing mast cell-targeted monoclonal and bispecific antibodies for chronic urticaria, inflammatory skin diseases, and systemic inflammatory conditions. ask →
• ATAIBECKLEY INC (ATAI) Health Care — A clinical-stage biotechnology company dedicated to developing innovative mental health therapies through a diverse pipeline of neuropsychiatric treatments. ask →
• TREVI THERAPEUTICS INC (TRVI) Health Care — Trevi Therapeutics is a clinical-stage biotech developing Haduvio, an oral, non-scheduled dual-action opioid receptor drug, to treat chronic cough associated with severe lung diseases like IPF. ask →
• SELLAS LIFE SCIENCES GROUP INC (SLS) Health Care — SELLAS Life Sciences is a clinical-stage biotech developing targeted immunotherapies and small molecule inhibitors to treat a variety of hematologic and solid tumor cancers. ask →
• VIRIDIAN THERAPEUTICS ORS INC (VRDN) Health Care — Viridian is a clinical-stage biopharmaceutical company developing potentially differentiated monoclonal antibody therapies for thyroid eye disease and autoimmune diseases, with lead candidate veligrotug advancing through late-stage trials against Amgen's Tepezza. ask →
• UFP TECHNOLOGIES INC (UFPT) Health Care — A specialized contract manufacturer producing custom single-use and single-patient medical devices for major OEMs across minimally invasive surgery, wound care, orthopedics, and biopharma applications. ask →
• GENERATE BIOMEDICINES INC (GENB) Health Care — Generate Biomedicines is a clinical-stage biotechnology company leveraging generative artificial intelligence to design novel, programmable protein therapeutics. ask →
• TYRA BIOSCIENCES INC (TYRA) Health Care — Tyra Biosciences is a clinical-stage biotech company developing precision small-molecule inhibitors to overcome drug resistance in cancer, particularly targeting FGFR-driven diseases. ask →
• FORTREA HOLDINGS INC (FTRE) Health Care — Fortrea is a global contract research organization that accelerates the delivery of life-changing treatments by providing flexible, science-driven clinical development solutions to pharmaceutical and medical device partners. ask →
• MAZE THERAPEUTICS INC (MAZE) Health Care — Maze Therapeutics leverages human genetics data and its Compass platform to discover and develop novel therapeutic candidates across multiple disease indications. ask →
• MAPLIGHT THERAPEUTICS INC (MPLT) Health Care — MapLight Therapeutics is a clinical-stage biopharmaceutical company dedicated to discovering and developing novel, targeted treatments for central nervous system disorders. ask →
• INNOVIVA INC (INVA) Health Care — A diversified biopharmaceutical company combining respiratory royalties from GSK blockbusters (BREO, ANORO) with a growing critical care and infectious disease platform (GIAPREZA, XACDURO, ZEVTERA, NUZOLVENCE). ask →
• INHIBRX BIOSCIENCES INC (INBX) Health Care — A clinical-stage biopharma company leveraging proprietary protein engineering to develop next-generation biologic therapeutics for hard-to-treat solid tumors. ask →
• CORVUS PHARMACEUTICALS INC (CRVS) Health Care — A clinical-stage biopharmaceutical company developing targeted ITK inhibitors to modulate immune function for the treatment of cancer and inflammatory diseases. ask →
• SAVARA INC (SVRA) Health Care — Savara is a clinical-stage biopharmaceutical company dedicated to developing innovative inhalable therapies for rare respiratory diseases. ask →
• Seaport Therapeutics, Inc. (SPTX) Health Care — Seaport Therapeutics is a clinical-stage biopharmaceutical company advancing a pipeline of novel therapeutics using its proprietary drug development platform. ask →
• SCHRODINGER INC (SDGR) Health Care — Physics-based computational platform that accelerates drug discovery and materials science by predicting molecular properties with high accuracy, enabling faster, cheaper, and more successful drug development. ask →
• CULLINAN THERAPEUTICS INC (CGEM) Health Care — Cullinan Therapeutics is a clinical-stage biopharmaceutical company developing targeted, innovative therapies for cancer and autoimmune diseases. ask →
• EYEPOINT INC (EYPT) Health Care — EyePoint Pharmaceuticals is a clinical-stage biopharma developing sustained-release treatments for retinal diseases including wet AMD and diabetic macular edema, with the approved product DEXYCU generating minimal revenue. ask →
• PHATHOM PHARMACEUTICALS INC (PHAT) Health Care — Phathom is a commercial-stage biopharmaceutical company commercializing VOQUEZNA, the first US-approved potassium-competitive acid blocker (PCAB) for gastrointestinal diseases including erosive GERD and H. pylori infection. ask →
• Odyssey Therapeutics, Inc. (ODTX) Health Care — A clinical-stage biotechnology company developing a pipeline of novel small molecule and protein therapeutic candidates. ask →
• ANNEXON INC (ANNX) Health Care — Annexon is a clinical-stage biotechnology company developing C1q-inhibitor therapies to treat neurodegenerative and autoimmune diseases driven by the classical complement pathway. ask →
• CRYOPORT INC (CYRX) Health Care — Cryoport is the leading provider of end-to-end temperature-controlled supply chain solutions specifically built for cell and gene therapies, from preclinical development through global commercialization. ask →
• ESPERION THERAPEUTICS INC (ESPR) Health Care — Esperion commercializes NEXLETOL and NEXLIZET, first-in-class non-statin ACLY inhibitors proven to reduce cardiovascular risk in statin-intolerant or statin-unwilling patients with elevated cholesterol. ask →
• ACLARIS THERAPEUTICS INC (ACRS) Health Care — Aclaris Therapeutics is a clinical-stage biopharmaceutical firm developing a pipeline of novel treatments for immuno-inflammatory diseases through a strategy of internal R&D and strategic third-party partnerships. ask →
• MONOPAR THERAPEUTICS INC (MNPR) Health Care — Monopar Therapeutics is a clinical-stage biopharmaceutical firm focused on developing innovative radiopharmaceuticals for cancer and specialized treatments for rare diseases like Wilson disease. ask →
• DESIGN THERAPEUTICS INC (DSGN) Health Care — A clinical-stage biotechnology company pioneering a novel class of small-molecule GeneTAC therapeutics to treat serious genetic diseases by modulating gene expression. ask →
• AURA BIOSCIENCES INC (AURA) Health Care — Aura Biosciences is a clinical-stage biotech developing precision Viral-like Drug Conjugate (VDC) therapies designed to treat solid tumors while preserving organ function. ask →

Not quite it? Describe exactly what you want →

Data: SEC EDGAR (filings) + Finnhub (fundamentals, delayed daily-close). Figures shown with their as-of date.

Last updated 2026-07-23.

Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date.